Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. . 64440. IXC Valuation Report MST. Yet since market announcement of Phase 2 completion, this. Created with Sketch. Also took placement stock @$1. Created with Sketch. Cannot wait. IXC Price at posting: 23. 0¢ Sentiment: Buy Disclosure: Held. ASX - Day TradingI sold around half my shares yesterday at 25c. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. Created with Sketch. DJPIN. Forex. Forums. Latest Posts ForumsHalf Yearly Report and AccountsWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. This was roughly 50/50 between lost wages and direct medical costs. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. . , page-20. Latest Posts. 1956773. Created with Sketch. ASX - Day Trading. 0. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. , page-17. As thread states post your questions here and let’s start compiling a list. Last updated 10. Created with Sketch. ASX - By Stock. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. IXC Valuation Report MST. Join the HotCopper ASX share market forum today for free. 0% $ODM 35. Initial FDA and EMA Advice on Presendin Development, page-3. I think having this out we can discuss on the way. ASX - Day TradingCreated with Sketch. We are a team of expert financial advisers each specialising in different, yet complementary areas. Created with Sketch. . Most bio's get acquired on P2 readouts, if results are strong early here. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Quarterly Activities/Appendix 4C Cash Flow Report. Target our investor community with our suite of Hotcopper Advertising opportunities. June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN. Created with Sketch. Invex Therapeutics Ltd. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Some people like to gamble on stocks, others invest. ASX - Day Trading. Reply. . With a team of 68. 26 area could be wrong and it could go for example to $3. 0 Great analysis. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. 76 (-1. Update - Notification regarding unquoted securities - IXC. **Close price adjusted for splits and dividend and/or capital gain distributions. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. Spot on - filled the 1. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Australian finance news, stock quotes, currency information and blogs0. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. . AX stock on Yahoo Finance. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Therefore Id bet the same bet with the same info again. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. ASX - By Stock. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. . ASX - By Stock. ASX - Day Trading. Forums. Although, IXC is trading about 3-4x lower than what I expect it to be. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. Loading interactive chart. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. A rolling snowball gathers snow as it falls down the hill . Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. 1. ASX - Day Trading. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Created with Sketch. Join the HotCopper ASX share market. ASX - Day Trading. Invex Granted Type C Meeting with FDA, page-2. . ASX - Day Trading. , page-2. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. ASX - By Stock. Market . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. 06KBNotification of cessation of securities - IXC. Forums. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. IXC (ASX) Ann: Trading Halt - HotCopper. ASX - By Stock. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. ASX - Short Term Trading. . . IXC Valuation Report MST. Created with Sketch. Join the HotCopper ASX share market forum today for free. Company has options because they have cash. IXC has alot of catching up to do. , page-3. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Created with Sketch. . Advertise on HotCopper. , page-5. Charts. ASX - Short Term Trading. 2. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. . Latest Posts. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. Transparency is our policy. In 2005, IIH cost the American health care. It's essentially a cashed up shell company right now it. Forums. Charts. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. I see it at perhaps $5 prior to readout. 79 -0. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. LoginJoin Now. 79 -0. . , page-3. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. ASX - By Stock. The fact it recovered and closed about the 1. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Click for more information. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Invex Receives Approval for Paediatric Plan from the EMA, page-3. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Latest Posts. ASX - Day Trading. Invex issued US patent for Traumatic Brain Injury. ASX - By Stock. ASX - By Stock. Join the HotCopper ASX share market forum today for free. Latest Posts. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. ASX - By Stock. 0¢ Sentiment: Buy Disclosure: Held. Advertise on HotCopper. 30 Haven’t supported share price since then on market . See page-34. . Update - Notification regarding unquoted securities - IXC. 59). Results of MeetingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. ASX - By Stock. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. . ASX - Day Trading. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Market . Theres alot of breakdowns above that are yet to be backtested. ASX - Short Term Trading. is there any news release, or SP increasing due to only the market showing interest, page-2. Andrew Forrest , or his entities have been involved with IXC since inception. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Latest Posts. . 5¢ INVEX THERAPEUTICS LTD - Discussion. When can we expect some update or. 4KB OECCreated with Sketch. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. My understanding is that NEU went from around $1. 5% last year. Last research or update on this I listened to was by FiftyOneCapital. Fully funded. Created with Sketch. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. 0% $ODM 35. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. ASX - By Stock. Market open. ASX - By Stock. Folks say we are pioneers of craft ice cream in Victoria. Learn more. ASX - Short Term Trading. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. . Market . , page-2. , page-5. Can't see how this doesn't push up soon, page-508. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - By Stock. . To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. Forums. Charts. Plans & Pricing. Last updated 15. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. IXC Price at posting: 37. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. Market . Created with Sketch. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. Share "Online registration will open 30 minutes before the Meeting. ASX - General. ASX - Day TradingAnother day…another approval. 00% 21. 0 Great. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. ASX - General. AVALANCHE. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. . Is it just me or has IXC gone very quiet. ASX - Short Term Trading. Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. Join HotCopper today. 0. . Created with Sketch. 10 cents a week and we will be at $2 plus in no time. . . $45M MC $30M Cash and a $1. Report Created with Sketch. Join the HotCopper ASX share market forum today for free. Probably been disappointed like all of us Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. Market . ASX - Day TradingI bought some today at 44. Created with Sketch. Market . Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Invex Therapeutics Lists on ASXNo worries mate :), page-15. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. June 15 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES WRITTEN RESPONSE FROM FDA ON TYPE C MEETING ON PHASE III CLINICAL TRIAL DESIGN FOR. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-9 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. Market . Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. Created with Sketch. 375,000. ASX - Short Term Trading. you post every single trade that is a sell onto Hotcopper. ASX - General. ASX - By Stock. IXC Price at posting: 38. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. ASX - Day Trading. . IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. Market . Charts. no point selling now. Created with Sketch. Last updated 15. ASX - General. ASX - Day TradingCreated with Sketch. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - By Stock. 1950. . ASX - By Stock. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. Created with Sketch. ASX - Short Term Trading. Trading HaltCreated with Sketch. 76 (-1. IXC (ASX) Ann: Trading Halt - HotCopper. . Market . . Created with Sketch. ASX - Short Term Trading. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. I think having this out we can discuss on the way. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Forums. 43 Sentiment: Buy Disclosure: Held. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. . Proposed Capital Return to Shareholders of $14. Notice of Investor Call and Presentation, page-2. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. . You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. Share IXC needs to be proactive and release a statement. is 19. IXC below Example of that is NEU Investor Presentation, page-3. Read in the announcement, has changed name and he has bought more ixc, page-2. Sentiment for Invex Therapeutics Ltd. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. Australian finance news, stock quotes, currency information and blogs Active Funds. Appendix 4E and Annual Report, page-2. Created with Sketch. ASX - General. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. 3¢. Very impressive. 0. . Market . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - By Stock. 3¢. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. ASX - By Stock. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Forums. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. About 90 percent of the U. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. a shell trading below cash backing, ripe. , page-35. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. . Currency in USD 38. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Here come the vultures. Market . 3¢. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Orphan drug status. Andrew Forrest , or his entities have been involved with IXC since inception. , page-6. Invex Therapeutics Ltd. Created with Sketch. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Share. Created with Sketch.